NTPC Darlipali Thermal Power Station's Unit 2 to start commercial operation from September 1

NTPC Darlipali Thermal Power Station's Unit 2 to start commercial operation from September 1

PTIUpdated: Tuesday, August 31, 2021, 12:12 PM IST
article-image
The Unit-1 of Darlipali power project had started commercial operation in March 2020./ Representational image |

State-run power giant NTPC on Tuesday said the second unit of Darlipali Super Thermal Power Station in Odisha will start commercial operation from September 1.

"Unit-2 of 800 MW capacity of Darlipali Super Thermal Power Station, Stage-I (2 x 800 MW) is declared on commercial operation w.e.f 00:00 Hrs of 01.09.2021," NTPC said in a regulatory filing.

The Unit-1 of Darlipali power project had started commercial operation in March 2020.

"With this, the commercial capacity of NTPC and NTPC group will become 53,225 MW and 66,650 MW respectively," the filing added.

Shares of NTPC Ltd were trading at Rs 115.55 apiece on BSE, up 0.48 per cent over its previous close.

RECENT STORIES

Trump Admin Scraps H-1B Lottery, Prioritizes High-Skilled, High-Paid Workers To Protect US Jobs

Trump Admin Scraps H-1B Lottery, Prioritizes High-Skilled, High-Paid Workers To Protect US Jobs

Unacademy Tightens ESOP Rules For Ex-Staff, Shorter Exercise Window Sparks Criticism Amid Takeover...

Unacademy Tightens ESOP Rules For Ex-Staff, Shorter Exercise Window Sparks Criticism Amid Takeover...

Rupee Strengthens 12 Paise To 89.51 On RBI's ₹3 Lakh Crore Liquidity Boost, Weaker Dollar

Rupee Strengthens 12 Paise To 89.51 On RBI's ₹3 Lakh Crore Liquidity Boost, Weaker Dollar

Sensex, Nifty Edge Higher Amid Positive Global Cues; Midcaps, Smallcaps Outperform

Sensex, Nifty Edge Higher Amid Positive Global Cues; Midcaps, Smallcaps Outperform

Biocon Out-Licenses Diabetes Drug To Ajanta Pharma For Marketing In 23 Countries

Biocon Out-Licenses Diabetes Drug To Ajanta Pharma For Marketing In 23 Countries